Banjo Health vs Forus (2026)

AI Health Index verifiedAugust 4, 2026
Verdict

The two ends of a pharmacy prior authorization, automated separately. Banjo sits inside the plan or pharmacy benefit manager, reading prescriber notes directly and producing a structured recommendation with the evidence attached, backed by certification at the more demanding risk based tier. Forus sits at the point of prescribing, generating and submitting the authorisation, drafting the appeal and routing to pharmacy, free to the provider. Between them a request can now be written by one model and adjudicated by another while a patient waits for a medicine. Neither publishes the number that would show its side is calibrated. And on Forus the question to ask first is who pays, because a free platform routing prescriptions has an economic relationship somewhere in the chain.

The case for Banjo Health
  • It is pharmacy benefit weighted and reads prescriber notes directly, producing an inspectable structured recommendation with the evidence attached rather than a score.
  • Certification is held at the risk based two year tier, which incorporates privacy requirements and is the more demanding assessment.
  • For a plan or pharmacy benefit manager, the determination workflow is the constraint and this is built for it.
The case for Forus
  • It automates the provider's side of the same transaction, generating and submitting the authorisation, drafting appeals and routing to pharmacy, at no cost to the prescriber.
  • Coverage is stated as any drug, any insurance, any pharmacy, embedded at the point of prescribing rather than in a back office.
  • It states plainly that protected health information is covered under a business associate agreement, alongside a typed attestation.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Banjo Health and Forus are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact Banjo Health Forus
Primary category RCM & Prior Auth AI RCM & Prior Auth AI
Founded Not recorded 2022
Headquarters Washington, District of Columbia New York, New York, United States
Website banjohealth.com forus.com
Attribute Matrix

Side by Side

Axis
B
Banjo Health
F
Forus
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Citable Summaries

Each record in one paragraph

Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.

Banjo Health

The AI Health Index awards Banjo Health its top capability grade on AI Centrality and Setting and Specialty Coverage. Set against Forus, Banjo Health grades higher on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and Clinical and Operational Evidence. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

Forus

The AI Health Index awards Forus its top capability grade on AI Centrality and HIPAA and BAA Posture. Set against Banjo Health, Forus grades higher on HIPAA and BAA Posture and Commercial Transparency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

FAQ

Questions buyers ask

Should we choose Banjo Health or Forus?

On the axes where the AI Health Index separates them, Banjo Health grades higher on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and Clinical and Operational Evidence, and Forus grades higher on HIPAA and BAA Posture and Commercial Transparency. Banjo Health leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.

Where do Banjo Health and Forus differ most?

The widest separation the AI Health Index records between Banjo Health and Forus is on Model and Technology Transparency, where Banjo Health grades B and Forus grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.

Where do Banjo Health and Forus grade the same?

The AI Health Index grades Banjo Health and Forus the same on several axes, including AI Centrality, Autonomy and Oversight Model and AI Safety and PHI Stewardship. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.

Disclosure

One of these decides the authorisation and the other submits it, which makes the pair a closed loop with a patient waiting inside it. Neither publishes the calibration number for its side: the proportion of AI informed denials overturned on appeal, and the proportion of automated submissions approved first time.

A product that is free to the provider is paid for by someone else, and in medication access that is usually a manufacturer or pharmacy channel, so establish who funds it and what data flows back. Neither publishes a bias evaluation, in a workflow where the output determines whether a patient starts therapy.